219 related articles for article (PubMed ID: 24098792)
1. The immuno-regulatory impact of orally-administered Hypericum perforatum extract on Balb/C mice inoculated with H1n1 influenza A virus.
Huang N; Singh N; Yoon K; Loiacono CM; Kohut ML; Birt DF
PLoS One; 2013; 8(9):e76491. PubMed ID: 24098792
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of lipopolysaccharide-induced macrophage inflammation by 4 compounds in Hypericum perforatum extract is partially dependent on the activation of SOCS3.
Huang N; Rizshsky L; Hauck CC; Nikolau BJ; Murphy PA; Birt DF
Phytochemistry; 2012 Apr; 76():106-16. PubMed ID: 22245632
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of Hypericum perforatum L. extract for mice infected with an influenza A virus.
Xiuying P; Jianping L; Ruofeng S; Liye Z; Xuehong W; Yan L
Can J Physiol Pharmacol; 2012 Feb; 90(2):123-30. PubMed ID: 22260349
[TBL] [Abstract][Full Text] [Related]
4. Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice.
Liu B; Bao L; Wang L; Li F; Wen M; Li H; Deng W; Zhang X; Cao B
J Microbiol Immunol Infect; 2021 Jun; 54(3):396-403. PubMed ID: 31780358
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1).
Zarogiannis SG; Noah JW; Jurkuvenaite A; Steele C; Matalon S; Noah DL
Life Sci; 2012 Mar; 90(11-12):440-5. PubMed ID: 22269828
[TBL] [Abstract][Full Text] [Related]
6. Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response.
Zhou HX; Li RF; Wang YF; Shen LH; Cai LH; Weng YC; Zhang HR; Chen XX; Wu X; Chen RF; Jiang HM; Wang C; Yang M; Lu J; Luo XD; Jiang Z; Yang ZF
Phytomedicine; 2020 Oct; 77():153272. PubMed ID: 32702592
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulaton and attenuation of lethal influenza A virus infection by oral administration with KIOM-C.
Kim EH; Pascua PN; Song MS; Baek YH; Kwon HI; Park SJ; Lim GJ; Kim SM; Decano A; Lee KJ; Cho WK; Ma JY; Choi YK
Antiviral Res; 2013 Jun; 98(3):386-93. PubMed ID: 23588232
[TBL] [Abstract][Full Text] [Related]
8. In vivo effect of quantified flavonoids-enriched extract of Scutellaria baicalensis root on acute lung injury induced by influenza A virus.
Zhi HJ; Zhu HY; Zhang YY; Lu Y; Li H; Chen DF
Phytomedicine; 2019 Apr; 57():105-116. PubMed ID: 30668313
[TBL] [Abstract][Full Text] [Related]
9. Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection.
Wei H; Wang S; Chen Q; Chen Y; Chi X; Zhang L; Huang S; Gao GF; Chen JL
PLoS Pathog; 2014 Jan; 10(1):e1003845. PubMed ID: 24391501
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary immune cells and inflammatory cytokine dysregulation are associated with mortality of IL-1R1
Guo L; Wang YC; Mei JJ; Ning RT; Wang JJ; Li JQ; Wang X; Zheng HW; Fan HT; Liu LD
Zool Res; 2017 May; 38(3):146-154. PubMed ID: 28585438
[TBL] [Abstract][Full Text] [Related]
11. Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokine/chemokine production in macrophages.
Ramírez-Martínez G; Cruz-Lagunas A; Jiménez-Alvarez L; Espinosa E; Ortíz-Quintero B; Santos-Mendoza T; Herrera MT; Canché-Pool E; Mendoza C; Bañales JL; García-Moreno SA; Morán J; Cabello C; Orozco L; Aguilar-Delfín I; Hidalgo-Miranda A; Romero S; Suratt BT; Selman M; Zúñiga J
Cytokine; 2013 Apr; 62(1):151-9. PubMed ID: 23434273
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
[TBL] [Abstract][Full Text] [Related]
13. Mahuang Xixin Fuzi decoction protects the BALB/c-nude mice infected with influenza A virus by reducing inflammatory cytokines storm and weakly regulating SIgA immune response.
Liu M; Yang J; Qian S; Sun Z; Jin Y; Liu X; Ye D; Rong R; Yang Y
J Ethnopharmacol; 2023 Mar; 304():116070. PubMed ID: 36549371
[TBL] [Abstract][Full Text] [Related]
14. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice.
Shi X; Zhou W; Huang H; Zhu H; Zhou P; Zhu H; Ju D
Crit Care; 2013 Dec; 17(6):R301. PubMed ID: 24373231
[TBL] [Abstract][Full Text] [Related]
16. Analysis of bronchoalveolar lavage fluid in a mouse model of bronchial asthma and H1N1 2009 infection.
Okada S; Hasegawa S; Hasegawa H; Ainai A; Atsuta R; Ikemoto K; Sasaki K; Toda S; Shirabe K; Takahara M; Harada S; Morishima T; Ichiyama T
Cytokine; 2013 Aug; 63(2):194-200. PubMed ID: 23706975
[TBL] [Abstract][Full Text] [Related]
17. Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice.
Chen H; Zheng X; Nicholas J; Humes ST; Loeb JC; Robinson SE; Bisesi JH; Das D; Saleh NB; Castleman WL; Lednicky JA; Sabo-Attwood T
Virol J; 2017 Dec; 14(1):242. PubMed ID: 29273069
[TBL] [Abstract][Full Text] [Related]
18. Polygalasaponin F treats mice with pneumonia induced by influenza virus.
Ye Y; Wang H; Liu J; Zhao F; Xu P
Inflammopharmacology; 2020 Feb; 28(1):299-310. PubMed ID: 31446589
[TBL] [Abstract][Full Text] [Related]
19. Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6.
Liu S; Yan R; Chen B; Pan Q; Chen Y; Hong J; Zhang L; Liu W; Wang S; Chen JL
Front Immunol; 2019; 10():1843. PubMed ID: 31474976
[TBL] [Abstract][Full Text] [Related]
20. Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with Oseltamivir.
Hong EH; Song JH; Shim A; Lee BR; Kwon BE; Song HH; Kim YJ; Chang SY; Jeong HG; Kim JG; Seo SU; Kim H; Kwon Y; Ko HJ
PLoS One; 2015; 10(6):e0131089. PubMed ID: 26098681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
